AVTX icon

Avalo Therapeutics
AVTX

Overview Fund Trends Analyst Outlook Journalist POV

16 hedge funds and large institutions have $53.6M invested in Avalo Therapeutics in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$826K
2
+$560K
3
+$194K
4
AC
Armistice Capital
New York
+$157K
5
Citadel Advisors
Citadel Advisors
Florida
+$84K

Top Sellers

1
-$506K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$51.4M
2
$826K
3
$560K
4
$194K
5
$182K
6
$84K
7
$74K
8
$62K
9
$54K
10
$42K
11
$36K
12
$32K
13
$27K
14
$12K
15
$10K
16
$7K
17
$3K
18
$3K
19
–